InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating)’s share price fell 6.4% during mid-day trading on Thursday . The company traded as low as $1.16 and last traded at $1.17. 23,971 shares changed hands during trading, a decline of 97% from the average session volume of 803,593 shares. The stock had previously closed at $1.25. InMed […]
InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totalling 93,800 shares, a drop of 25.7% from the April 15th total of 126,300 shares. Based on an average daily volume of 595,100 shares, the […]
InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating) dropped 6.4% on Thursday . The stock traded as low as $1.16 and last traded at $1.17. Approximately 23,971 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 803,593 shares. The stock had previously closed at $1.25. InMed Pharmaceuticals Stock Performance […]
Marks the first time a Phase 2 trial has studied a cannabinol (CBN) formulation as a treatment option for any diseaseData expected to be released in early calendar Q3 2023Vancouver, British Columbia (Newsfile
/PRNewswire/ The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around.